Stoehr, R., Hitzenbichler, F., Kneitz, B., Hammerschmied, C. G., Burger, M., Tannapfel, A., & Hartmann, A. (2008). Mdm2-SNP309 polymorphism in prostate cancer: No evidence for association with increased risk or histopathological tumour characteristics. Nature Publishing Group.

Stoehr, R., F. Hitzenbichler, B. Kneitz, C G. Hammerschmied, M. Burger, A. Tannapfel, and A. Hartmann. Mdm2-SNP309 Polymorphism in Prostate Cancer: No Evidence for Association With Increased Risk or Histopathological Tumour Characteristics. Nature Publishing Group, 2008.

Stoehr, R., et al. Mdm2-SNP309 Polymorphism in Prostate Cancer: No Evidence for Association With Increased Risk or Histopathological Tumour Characteristics. Nature Publishing Group, 2008.